Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Biosimilar Implementation: How US Can Learn From EU

This article was originally published in PharmAsia News

Executive Summary

Differences in payer policies have limited the biosimilar opportunity in some EU nations, and a new report points to examples the US should replicate or avoid as biosimilars are introduced domestically, providing useful pointers to Asian firms active in the sector and looking to make filings in the US.



Related Companies